Publications in collaboration with researchers from Hospital Universitario de Salamanca (19)

2021

  1. Evaluation of current amikacin dosing recommendations and development of an interactive nomogram: The role of albumin

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-13

2020

  1. Amikacin initial dosage in patients with hypoalbuminaemia: an interactive tool based on a population pharmacokinetic approach

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 8, pp. 2222-2231

2019

  1. Evaluation of renal function equations to predict amikacin clearance

    Expert Review of Clinical Pharmacology, Vol. 12, Núm. 8, pp. 805-813

2017

  1. Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia

    Expert Review of Clinical Pharmacology, Vol. 10, Núm. 8, pp. 911-917

2009

  1. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients

    Journal of Pharmacy and Pharmacology, Vol. 61, Núm. 6, pp. 759-766

2008

  1. Recomendaciones para la monitorización de antibióticos en pacientes críticos ingresados en UCI

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Recommendations for antibiotic monitoring in ICU patients

    Farmacia Hospitalaria

2005

  1. Time-dependent pharmacokinetics of cyclosporine (Neoral®) in de novo renal transplant patients

    Journal of Clinical Pharmacy and Therapeutics, Vol. 30, Núm. 6, pp. 549-557

2004

  1. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates

    Journal of Antimicrobial Chemotherapy, Vol. 54, Núm. 1, pp. 193-198

2003

  1. Pharmacokinetic study of the digoxin-acenocoumarol interaction in rabbits

    Biological and Pharmaceutical Bulletin, Vol. 26, Núm. 6, pp. 813-817

1999

  1. Population pharmacokinetics of amikacin in patients with haematological malignancies

    Journal of Antimicrobial Chemotherapy, Vol. 44, Núm. 2, pp. 235-242

1998

  1. Influence of clinical diagnosis in the population pharmacokinetics of amikacin in intensive care unit patients

    Clinical Drug Investigation, Vol. 15, Núm. 5, pp. 435-444

1996

  1. Bayesian forecasting in paediatric populations

    Clinical Pharmacokinetics

  2. Influence of pharmacokinetic model on vancomycin peak concentration targets

    Therapeutic Drug Monitoring, Vol. 18, Núm. 2, pp. 145-148

  3. Pharmacokinetics of amikacin in intensive care unit patients

    Journal of Clinical Pharmacy and Therapeutics, Vol. 21, Núm. 6, pp. 417-421

1993

  1. Digoxin pharmacokinetics in patients with high serum digoxin concentrations

    Journal of Clinical Pharmacy and Therapeutics, Vol. 18, Núm. 1, pp. 63-68

1989

  1. Biological and kinetic behavior of aluminium overload in chronic renal failure during desferrioxamine administration

    Nefrologia, Vol. 9, Núm. 1, pp. 72-77

1985

  1. Urinary kinetics of triiodothyronine and their modification with aging

    Hormone and Metabolic Research, Vol. 17, Núm. 7, pp. 366-369

1983

  1. Serum lidocaine levels in patients undergoing fibrobronchoscopy

    Therapeutic Drug Monitoring, Vol. 5, Núm. 2, pp. 201-203